Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $811.89 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $220.22 | 7 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $174.69 | 4 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $132.68 | 3 | $0 (2018) |
| Genentech USA, Inc. | $128.10 | 2 | $0 (2017) |
| Gilead Sciences Inc | $125.00 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $19.22 | 1 | $0 (2019) |
| Mannkind Corporation | $11.98 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $147.08 | 2 | GlaxoSmithKline, LLC. ($125.00) |
| 2019 | $53.98 | 3 | AstraZeneca Pharmaceuticals LP ($19.44) |
| 2018 | $295.13 | 7 | AstraZeneca Pharmaceuticals LP ($133.17) |
| 2017 | $315.70 | 7 | Genentech USA, Inc. ($128.10) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/06/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Respiratory | ||||||
| 03/05/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO, STEGLUJAN | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/19/2019 | GlaxoSmithKline, LLC. | ANORO (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: RESPIRATORY | ||||||
| 07/29/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Respiratory | ||||||
| 11/20/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $115.35 | General |
| Category: Respiratory | ||||||
| 10/29/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Respiratory | ||||||
| 09/13/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $122.52 | General |
| 02/16/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2017 | Gilead Sciences Inc | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HBV | ||||||
| 09/12/2017 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $117.02 | General |
| 09/08/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Immunology | ||||||
| 08/16/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: RESPIRATORY | ||||||
| 04/28/2017 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: DIABETES MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 7 | 188 | 252 | $24,533 | $12,215 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 75 | $7,500 | $4,674 | 62.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 43 | 44 | $8,800 | $3,591 | 40.8% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 31 | 31 | $3,150 | $1,605 | 51.0% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2020 | 11 | 21 | $2,709 | $1,458 | 53.8% |
| 94664 | Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device | Office | 2020 | 32 | 32 | $1,089 | $519.26 | 47.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 17 | 19 | $1,045 | $278.36 | 26.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 21 | 30 | $240.00 | $88.20 | 36.8% |
About Dr. Premanath Banad, MD
Dr. Premanath Banad, MD is a Pulmonary Disease healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518946714.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Premanath Banad, MD has received a total of $811.89 in payments from pharmaceutical and medical device companies, with $147.08 received in 2020. These payments were reported across 19 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($811.89).
As a Medicare-enrolled provider, Banad has provided services to 188 Medicare beneficiaries, totaling 252 services with total Medicare billing of $12,215. Data is available for 1 year (2020–2020), covering 7 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Bronx, NY
- Active Since 01/16/2006
- Last Updated 05/08/2014
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518946714
Products in Payments
- FASENRA (Drug) $155.25
- TRELEGY ELLIPTA (Drug) $136.17
- Vemlidy (Drug) $125.00
- ANORO (Drug) $64.05
- BREO (Drug) $20.00
- SYMBICORT (Drug) $19.44
- JANUVIA (Drug) $19.22
- AFREZZA (Drug) $11.98
- Esbriet (Biological) $11.08
- SPIRIVA (Drug) $10.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Bronx
Dr. Raji Ayinla, M.d, M.D
Pulmonary Disease — Payments: $699,684
Peter Dicpinigaitis, Md, MD
Pulmonary Disease — Payments: $305,607
Neomi Shah, M.d, M.D
Pulmonary Disease — Payments: $16,397
Richard Deluca, M.d, M.D
Pulmonary Disease — Payments: $14,463
Dr. Samuel Deleon, M.d, M.D
Pulmonary Disease — Payments: $11,703
Dr. Manuel Cabrera, Md, MD
Pulmonary Disease — Payments: $7,790